The impact of highly effective modulator therapy on gastrointestinal, hepatic, and nutritional outcomes in cystic fibrosis
Journal of Pediatric Gastroenterology and Nutrition · 18.11.2026
DOI: 10.1002/jpn3.70670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 18.11.2026. Verfasst von Alexandra Pottorff und 6 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Cystic fibrosis (CF) is a multisystemic disease that has implications throughout the gastrointestinal (GI) tract and is a significant cause of morbidity for people with CF (PwCF). The introduction of highly effective modulator therapy (HEMT) has led to major implications in the health and life expectancy of PwCF. However, the influence of HEMT on GI manifestations for PwCF is less clear and complex. This paper performs a review of the current literature assessing the impact of HEMT on GI manifestations related to CF. We review the implications of HEMT on the upper GI tract, pancreas, liver, lower GI tract, and nutrition. HEMT has a positive impact on overall weight and nutrition but may lead to greater than recommended weight gain. HEMT may also lead to improved pancreatic function when started at a young age, may improve meconium ileus in the neonatal period, and may improve intestinal inflammation. There is less clear evidence on the impact of HEMT on reflux, bloating, constipation, distal intestinal obstruction syndrome, and pancreatitis. There does not appear to be an improvement in CF hepatobiliary disease (CFHBI) with HEMT, and those taking it should be monitored for drug‐induced injury (DILI). HEMT does show promising benefits for some GI manifestations of CF. However, there continues to be significant morbidity from GI manifestations in PwCF despite HEMT. Further research would benefit the understanding and implications of HEMT in this realm.
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Pottorff, A., Mathews, S., Wood, W., Lazar, L., Mehta, M., Narayan, S., & Sathe, M. (2026). The impact of highly effective modulator therapy on gastrointestinal, hepatic, and nutritional outcomes in cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70670
Vancouver
Pottorff A, Mathews S, Wood W, Lazar L, Mehta M, Narayan S, et al. The impact of highly effective modulator therapy on gastrointestinal, hepatic, and nutritional outcomes in cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70670
BibTeX
@article{Pottorff2026,
author = {Pottorff, Alexandra and Mathews, Stacy and Wood, William and Lazar, Lauren and Mehta, Megha and Narayan, Sangeetha and Sathe, Meghana},
title = {The impact of highly effective modulator therapy on gastrointestinal, hepatic, and nutritional outcomes in cystic fibrosis},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70670}
}
EUVIMED